Works matching IS 22351795 AND DT 2021 AND VI 10 AND IP 4

Results: 12

Front & Back Matter.
Published in:
Liver Cancer (2235-1795), 2021, v. 10, n. 4, p. 1, doi. 10.1159/000518567
Publication type:
Article
APPLE News.
Published in:
Liver Cancer (2235-1795), 2021, v. 10, n. 4, p. 396, doi. 10.1159/000518226
Publication type:
Article
Immunological Microenvironment Predicts the Survival of the Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 Antibody.
Published in:
Liver Cancer (2235-1795), 2021, v. 10, n. 4, p. 380, doi. 10.1159/000516899
By:
- Morita, Masahiro;
- Nishida, Naoshi;
- Sakai, Kazuko;
- Aoki, Tomoko;
- Chishina, Hirokazu;
- Takita, Masahiro;
- Ida, Hiroshi;
- Hagiwara, Satoru;
- Minami, Yasunori;
- Ueshima, Kazuomi;
- Nishio, Kazuto;
- Kobayashi, Yukari;
- Kakimi, Kazuhiro;
- Kudo, Masatoshi
Publication type:
Article
Impaired Response to Immunotherapy in Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma?
Published in:
2021
By:
- Kudo, Masatoshi
Publication type:
Editorial
Is the Strongest Level of Medical Evidence Always Required for Guidelines Recommendations?
Published in:
2021
By:
- Ravaioli, Matteo;
- Piscaglia, Fabio;
- Cillo, Umberto;
- Brandi, Giovanni;
- Sessa, Maurizio;
- Germinario, Giuliana;
- Golfieri, Rita;
- Cappelli, Alberta;
- Morelli, Maria C.;
- Siniscalchi, Antonio;
- D'Errico, Antonietta;
- Cescon, Matteo;
- Iannone, Primiano;
- Trevisani, Franco
Publication type:
Letter
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma.
Published in:
Liver Cancer (2235-1795), 2021, v. 10, n. 4, p. 370, doi. 10.1159/000515551
By:
- Tovoli, Francesco;
- Dadduzio, Vincenzo;
- De Lorenzo, Stefania;
- Rimassa, Lorenza;
- Masi, Gianluca;
- Iavarone, Massimo;
- Marra, Fabio;
- Garajova, Ingrid;
- Brizzi, Maria Pia;
- Daniele, Bruno;
- Trevisani, Franco;
- Messina, Carlo;
- Di Clemente, Francesco;
- Pini, Sara;
- Cabibbo, Giuseppe;
- Granito, Alessandro;
- Rizzato, Mario Domenico;
- Zagonel, Vittorina;
- Brandi, Giovanni;
- Pressiani, Tiziana
Publication type:
Article
Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort.
Published in:
Liver Cancer (2235-1795), 2021, v. 10, n. 4, p. 360, doi. 10.1159/000515490
By:
- Finkelmeier, Fabian;
- Scheiner, Bernhard;
- Leyh, Catherine;
- Best, Jan;
- Fründt, Thorben Wilhelm;
- Czauderna, Carolin;
- Beutel, Alica;
- Bettinger, Dominik;
- Weiß, Johannes;
- Meischl, Tobias;
- Kütting, Fabian;
- Waldschmidt, Dirk-Thomas;
- Radu, Pompilia;
- Schultheiß, Michael;
- Peiffer, Kai-Henrik;
- Ettrich, Thomas J.;
- Weinmann, Arndt;
- Wege, Henning;
- Venerito, Marino;
- Dufour, Jean-Francois
Publication type:
Article
Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma.
Published in:
Liver Cancer (2235-1795), 2021, v. 10, n. 4, p. 346, doi. 10.1159/000515305
By:
- Hsu, Chia-Lang;
- Ou, Da-Liang;
- Bai, Li-Yuan;
- Chen, Chia-Wei;
- Lin, Li;
- Huang, Shiu-Feng;
- Cheng, Ann-Lii;
- Jeng, Yung-Ming;
- Hsu, Chiun
Publication type:
Article
Disease Burden, Risk Factors, and Recent Trends of Liver Cancer: A Global Country-Level Analysis.
Published in:
Liver Cancer (2235-1795), 2021, v. 10, n. 4, p. 330, doi. 10.1159/000515304
By:
- Huang, Junjie;
- Lok, Veeleah;
- Ngai, Chun Ho;
- Chu, Cedric;
- Patel, Harsh K.;
- Thoguluva Chandraseka, Viveksandeep;
- Zhang, Lin;
- Chen, Ping;
- Wang, Shanjuan;
- Lao, Xiang-Qian;
- Tse, Lap Ah;
- Xu, Wanghong;
- Zheng, Zhi-Jie;
- Wong, Martin C.S.
Publication type:
Article
Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations.
Published in:
Liver Cancer (2235-1795), 2021, v. 10, n. 4, p. 320, doi. 10.1159/000514313
By:
- Zhu, Xiao-Dong;
- Huang, Cheng;
- Shen, Ying-Hao;
- Ji, Yuan;
- Ge, Ning-Ling;
- Qu, Xu-Dong;
- Chen, Lingli;
- Shi, Wen-Kai;
- Li, Mei-Ling;
- Zhu, Jin-Jin;
- Tan, Chang-Jun;
- Tang, Zhao-You;
- Zhou, Jian;
- Fan, Jia;
- Sun, Hui-Chuan
Publication type:
Article
Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals.
Published in:
Liver Cancer (2235-1795), 2021, v. 10, n. 4, p. 309, doi. 10.1159/000513705
By:
- Minami, Tatsuya;
- Tateishi, Ryosuke;
- Fujiwara, Naoto;
- Nakagomi, Ryo;
- Nakatsuka, Takuma;
- Sato, Masaya;
- Uchino, Koji;
- Enooku, Kenichiro;
- Nakagawa, Hayato;
- Fujinaga, Hidetaka;
- Izumiya, Masashi;
- Hanajiri, Kazuyuki;
- Asaoka, Yoshinari;
- Kondo, Yuji;
- Tanaka, Yasuo;
- Otsuka, Motoyuki;
- Ohki, Takamasa;
- Arai, Masahiro;
- Tanaka, Atsushi;
- Yasuda, Kiyomi
Publication type:
Article
Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study.
Published in:
Liver Cancer (2235-1795), 2021, v. 10, n. 4, p. 296, doi. 10.1159/000513486
By:
- Qin, Shukui;
- Ren, Zhenggang;
- Feng, Yin-Hsun;
- Yau, Thomas;
- Wang, Baocheng;
- Zhao, Haitao;
- Bai, Yuxian;
- Gu, Shanzhi;
- Li, Lindong;
- Hernandez, Sairy;
- Xu, Derek-Zhen;
- Mulla, Sohail;
- Wang, Yifan;
- Shao, Hui;
- Cheng, Ann Lii
Publication type:
Article